|
1
|
Gonnissen A, Isebaert S and Haustermans K:
Hedgehog signaling in prostate cancer and its therapeutic
implication. Int J Mol Sci. 14:13979–14007. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guo R, Cai L, Fan Y, Jin J, Zhou L and
Zhang K: Magnetic resonance imaging on disease reclassification
among active surveillance candidates with low-risk prostate cancer:
A diagnostic meta-analysis. Prostate Cancer Prostatic Dis.
18:221–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen M, Carkner R and Buttyan R: The
hedgehog/Gli signaling paradigm in prostate cancer. Exp Rev
Endocrinol Metab. 6:453–467. 2011. View Article : Google Scholar
|
|
4
|
Kim TJ, Lee JY, Hwang TK, Kang CS and Choi
YJ: Hedgehog signaling protein expression and its association with
prognostic parameters in prostate cancer: A retrospective study
from the view point of new 2010 anatomic stage/prognostic groups. J
Sur Oncol. 104:472–479. 2011. View Article : Google Scholar
|
|
5
|
Jiang J and Hui CC: Hedgehog signaling in
development and cancer. Dev Cell. 15:801–812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Onishi H and Katano M: Hedgehog signaling
pathway as a therapeutic target in various types of cancer. Cancer
Sci. 102:1756–1760. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rubin LL and de Sauvage FJ: Targeting the
Hedgehog pathway in cancer. Nat Rev Drug Discov. 5:1026–1033. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG,
Lang JY, Li CW, Hsu JL, Miller SA, Wang X, et al: The crosstalk of
mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 21:374–387. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lauth M and Toftgård R: Non-canonical
activation of GLI transcription factors: Implications for targeted
anti-cancer therapy. Cell. 6:2458–2463. 2007.
|
|
10
|
Riobo NA, Haines GM and Emerson CP Jr:
Protein kinase C-delta and mitogen-activated protein/extracellular
signal-regulated kinase-1 control GLI activation in hedgehog
signaling. Cancer Res. 66:839–845. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Riobo NA, Lu K, Ai X, Haines GM and
Emerson CP Jr: Phosphoinositide 3-kinase and Akt are essential for
Sonic Hedgehog signaling. Proc Natl Acad Sci USA. 103:pp.
4505–4510. 2006; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang L, Xie G, Fan Q and Xie J: Activation
of the hedgehog-signaling pathway in human cancer and the clinical
implications. Oncogene. 29:469–481. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vandesompele J, De Preter K, Pattyn F,
Poppe B, Van Roy N, De Paepe A and Speleman F: Accurate
normalization of real-time quantitative RT-PCR data by geometric
averaging of multiple internal control genes. Genome Biol.
3:RESEARCH00342002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ebrahimi A, Larijani L, Moradi A and
Ebrahimi MR: Hedgehog signalling pathway: Carcinogenesis and
targeted therapy. Iran J Cancer Prev. 6:36–43. 2013.PubMed/NCBI
|
|
15
|
Chen G, Goto Y, Sakamoto R, Tanaka K,
Matsubara E, Nakamura M, Zheng H, Lu J, Takayanagi R and Nomura M:
GLI1, a crucial mediator of sonic hedgehog signaling in prostate
cancer, functions as a negative modulator for androgen receptor.
Biochem Biophys Res Commun. 404:809–815. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lauth M, Bergström A, Shimokawa T and
Toftgård R: Inhibition of GLI-mediated transcription and tumor cell
growth by small-molecule antagonists. Proc Natl Acad Sci USA.
104:pp. 8455–8460. 2007; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thayer SP, di Magliano MP, Heiser PW,
Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernández-del
Castillo C, Yajnik V, et al: Hedgehog is an early and late mediator
of pancreatic cancer tumorigenesis. Nature. 425:851–856. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pasca di Magliano M and Hebrok M: Hedgehog
signalling in cancer formation and maintenance. Nat Rev Cancer.
3:903–911. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Podlasek CA, Barnett DH, Clemens JQ, Bak
PM and Bushman W: Prostate development requires Sonic hedgehog
expressed by the urogenital sinus epithelium. Dev Biol. 209:28–39.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Datta S and Datta MW: Sonic Hedgehog
signaling in advanced prostate cancer. Cell Mol Life Sci.
63:435–448. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheng T, Li C, Zhang X, Chi S, He N, Chen
K, McCormick F, Gatalica Z and Xie J: Activation of the hedgehog
pathway in advanced prostate cancer. Mol Cancer. 3:292004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karhadkar SS, Bova GS, Abdallah N, Dhara
S, Gardner D, Maitra A, Isaacs JT, Berman DM and Beachy PA:
Hedgehog signalling in prostate regeneration, neoplasia and
metastasis. Nature. 431:707–712. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan L, Pepicelli CV, Dibble CC, Catbagan
W, Zarycki JL, Laciak R, Gipp J, Shaw A, Lamm ML, Munoz A, et al:
Hedgehog signaling promotes prostate xenograft tumor growth.
Endocrinology. 145:3961–3970. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Efstathiou E, Karlou M, Wen S, Hoang A,
Pettaway CA, Pisters LL, Maity S, Troncoso P and Logothetis CJ:
Integrated Hedgehog signaling is induced following castration in
human and murine prostate cancers. Prostate. 73:153–161. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thiyagarajan S, Bhatia N, Reagan-Shaw S,
Cozma D, Thomas-Tikhonenko A, Ahmad N and Spiegelman VS: Role of
GLI2 transcription factor in growth and tumorigenicity of prostate
cells. Cancer Res. 67:10642–10646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karlou M, Lu JF, Wu G, Maity S, Tzelepi V,
Navone NM, Hoang A, Logothetis CJ and Efstathiou E: Hedgehog
signaling inhibition by the small molecule smoothened inhibitor
GDC-0449 in the bone forming prostate cancer xenograft MDA PCa
118b. Prostate. 72:1638–1647. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taylor BS, Schultz N, Hieronymus H,
Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva
B, et al: Integrative genomic profiling of human prostate cancer.
Cancer Cell. 18:11–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Narita S, So A, Ettinger S, Hayashi N,
Muramaki M, Fazli L, Kim Y and Gleave ME: GLI2 knockdown using an
antisense oligonucleotide induces apoptosis and chemosensitizes
cells to paclitaxel in androgen-independent prostate cancer. Clin
Cancer Res. 14:5769–5777. 2008. View Article : Google Scholar : PubMed/NCBI
|
